You have 9 free searches left this month | for more free features.

matched unrelated donor

Showing 1 - 25 of 7,177

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

Recruiting
  • Chronic Granulomatous Disease
  • CGD
  • JSP191
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 5, 2023

Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)

Not yet recruiting
  • Idiopathic Aplastic Anemia
  • +2 more
  • HSCT Arm group
  • (no location specified)
Jun 10, 2022

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)

Recruiting
  • Sickle Cell Disease
  • Thalassemia Major
  • CliniMACS
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor

Terminated
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Haplo-Cord Transplant
  • Matched Unrelated Donor Transplant
  • Chicago, Illinois
    University of Chicago Cancer Center
Feb 22, 2021

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)

Active, not recruiting
  • Severe Aplastic Anemia
  • Los Angeles, California
  • +12 more
Feb 10, 2022

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia

Recruiting
  • Acquired Aplastic Anemia
  • +2 more
  • CliniMACs
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 1, 2022

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,

Withdrawn
  • Acute Myeloid Leukemia
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Hematologic Malignancies Trial in Milwaukee (CliniMACs)

Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Apr 4, 2022

Leukemia, MDS, Lymphomas Trial (rivogenlecleucel, Rimiducid)

Withdrawn
  • Leukemia
  • +4 more
  • (no location specified)
Oct 1, 2020

Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

Completed
  • Inherited Immune Deficiencies
  • Campath 1H
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021

AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

Recruiting
  • AML
  • +2 more
  • Peripheral blood stem cells
  • Bonn, Germany
  • +8 more
Aug 25, 2021

Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

Available
  • Leukemia
  • +2 more
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 2, 2021

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

Completed
  • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
  • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
  • CliniMACS (CD+3, CD+19 depletion)
  • +2 more
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Oct 21, 2021

DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

Recruiting
  • DOCK8 Deficiency
  • Reduced-intensity hematopoietic stem cell
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023